Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, the Company would like to intimate an update in respect of the approval granted to the Company for Production Linked Incentive (PLI) Scheme.
Sudarshan Pharma Industries Ltd Press Release Sep 08 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Sudarshan Pharma Industries Ltd Press Release Aug 18 2025
- Announcement under Regulation 30 (LODR)-Change in Management
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 12 2025
Later from Sudarshan Pharma Industries
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Sep 30 2025
- Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended 30-Sep-2025
- Sudarshan Pharma Industries Ltd Press Release Oct 15 2025
- Financial Results For The Quarter And Half Year Ended 30-Sep-2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries